FR1536M - Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite. - Google Patents

Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite.

Info

Publication number
FR1536M
FR1536M FR865226A FR865226A FR1536M FR 1536 M FR1536 M FR 1536M FR 865226 A FR865226 A FR 865226A FR 865226 A FR865226 A FR 865226A FR 1536 M FR1536 M FR 1536M
Authority
FR
France
Prior art keywords
myristyl
preservation
gamma
application
picolinium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR865226A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to FR865226A priority Critical patent/FR1536M/fr
Application granted granted Critical
Publication of FR1536M publication Critical patent/FR1536M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR865226A 1960-03-30 1961-06-16 Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite. Expired FR1536M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR865226A FR1536M (fr) 1960-03-30 1961-06-16 Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18521A US3097143A (en) 1960-03-30 1960-03-30 Myristyl-gamma-picolinium chloride preserved polio vaccine and its production
FR857220 1961-03-29
FR865226A FR1536M (fr) 1960-03-30 1961-06-16 Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite.

Publications (1)

Publication Number Publication Date
FR1536M true FR1536M (fr) 1962-10-22

Family

ID=21788364

Family Applications (1)

Application Number Title Priority Date Filing Date
FR865226A Expired FR1536M (fr) 1960-03-30 1961-06-16 Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite.

Country Status (5)

Country Link
US (1) US3097143A (fr)
BE (1) BE601852A (fr)
ES (1) ES266340A1 (fr)
FR (1) FR1536M (fr)
GB (1) GB949399A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002543A1 (fr) * 1989-08-15 1991-03-07 Massachusetts Institute Of Technology Compositions de vaccin stabilisees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793160A (en) * 1955-05-09 1957-05-21 Parke Davis & Co Poliomyelitis vaccine

Also Published As

Publication number Publication date
BE601852A (fr) 1961-09-27
ES266340A1 (es) 1961-07-01
GB949399A (en) 1964-02-12
US3097143A (en) 1963-07-09

Similar Documents

Publication Publication Date Title
BE604566A (fr) Matelas pneumatique.
BE594481A (fr) Perfectionnements apportés aux vaccins.
FR344M (fr) Nouvel agent thérapeutique.
FR1536M (fr) Application du chlorure de myristyl-gamma-picolinium a la conservation de vaccins anti-poliomyélite.
FR1175086A (fr) Agent stabilisateur du chlorure de polyvinyle
CH375231A (de) Rotationspumpe
BE563610R (fr) Derives du 2-propanol.
FR1207058A (fr) Soupape de pompe
FI29028A (fi) Kiertomäntäpumppu
FR149M (fr) Agent fongicide.
FR1282138A (fr) Porte-vêtement
DK94754C (da) Vandingspumpe.
AT213591B (de) Schuhgarderobe
BE557742A (fr) DERIVES HALOGENES D'alpha-AMINO-CETONES.
ES80439Y (es) Andador colgante giratoro
BE585090A (fr) Pieds pour meubles.
DK96375C (da) Gardinstang til draperi.
DK92857C (da) Gardinstang.
GR20491B (el) Μεθοδος προς παρατασιν της διατηρησεως συντετηρημενου αιματος.
FR1244970A (fr) Colonne tomographique
GR21068B (el) Στηριγμα δια ναυλον ντουλαπες.
GR20016B (el) Κυλιομενη βασις ψυγειων.
BE592032A (fr) Agent antimousse.
BE606346A (nl) Koelkast voor hoofdzakelijk pharmaceutisch gebruik
BE591082A (fr) Oscillateur à transistor réglable en frequence.